Drug Pipeline

Eloralintide Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
10
Active Studies
9
Recruiting
5
Phase 3
1
Top Sponsors
7
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-05 NCT07215559
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination…
Trial sites expanded: 38 -> 42 locations
2026-05-15 NCT07369011
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and…
Trial sites expanded: 123 -> 129 locations
2026-05-15 NCT07353931
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee…
Trial sites expanded: 154 -> 159 locations
2026-05-15 NCT06143956
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in…
Enrollment increased: 1217 -> 1481 participants
2026-05-15 NCT06143956
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in…
Trial arms changed: 5 -> 6
2026-05-15 NCT06143956
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in…
date change Primary completion pushed: 2026-06 -> 2027-09
2026-05-15 NCT06143956
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in…
date change Completion pushed: 2026-09 -> 2028-02
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-05-15 NCT07589608 A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in… Phase 2 Not Yet Recruiting
Active Studies by Phase
Phase 3
5
Phase 2
3
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07282600 A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type… Overweight Recruiting
NCT07321886 A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without… Obesity Recruiting
NCT07353931 Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee… Osteoarthritis Recruiting
NCT07369011 A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and… Sleep Apnea, Obstructive Recruiting
NCT07392190 A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are… Overweight Recruiting
Phase 2
NCT06143956 A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in… Obesity Recruiting
NCT07215559 A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination… Obesity Recruiting
NCT07589608 A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in… Overweight Not Yet Recruiting
Phase 1
NCT07426380 A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in… Kidney Disease Recruiting
NCT07401862 A Study of Eloralintide (LY3841136) in Participants With Different Levels of Liver Damage… Hepatic Insufficiency Recruiting
Sponsors Running Eloralintide Trials
Disease Areas
Get alerts when Eloralintide trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free